Telemanagement The researchers caution that these results need to be validated by additional studies. They also wonder if another drug, such as anastrozole , might be worthwhile trying in place of tamoxifen. Anastrozole is currently being compared to tamoxifen in ...
MarketWatch ... for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2 negative breast cancer (advanced HR+/HER2 negative breast cancer) in combination with exemestane after failure of treatment with letrozole or anastrozole . and more »
